W Wurst

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

23h-index1.9kcitations64works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(14), Drug Transport and Resistance Mechanisms(14), Helicobacter pylori-related gastroenterology studies(11), Gastroesophageal reflux and treatments(10), Asthma and respiratory diseases(8)

Publications64 total

Dose linearity and steady state pharmacokinetics of the new antiparkinson agent budipine after oral administration
International Journal of Clinical Pharmacology and Therapeutics·2009· 2 cited
A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy
CHEST Journal·2008· 95 cited
Dose‐Proportional Intraindividual Single‐ and Repeated‐Dose Pharmacokinetics of Roflumilast, an Oral, Once‐Daily Phosphodiesterase 4 Inhibitor
The Journal of Clinical Pharmacology·2006· 88 cited
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma
European Respiratory Journal·2006· 245 citedOpen Access
Two-Dimensional and Three-Dimensional Imaging Show Ciclesonide Has High Lung Deposition and Peripheral Distribution: A Nonrandomized Study in Healthy Volunteers
Journal of Aerosol Medicine·2006· 90 cited
Site-specific overexpression of corticotropin-releasing hormone (CRH) in the mouse brain – modelling central CRH system hyperactivity
Pharmacopsychiatry·2005· 2 cited
Inhibition of late asthmatic reaction in allergic asthma by the novel, selective PDE4 inhibitor Roflumilast
Journal of Allergy and Clinical Immunology·2004
Intragastric Ph During Continuous Infusion With Pantoprazole in Patients With Bleeding Peptic Ulcer
The American Journal of Gastroenterology·2003· 69 cited
A new self assessed questionnaire for the intensity and frequency of symptoms of dyspepsia: Construction and validation
Gastroenterology·2003Open Access
Treatment of Acute Respiratory Distress Syndrome with Recombinant Surfactant Protein C Surfactant
American Journal of Respiratory and Critical Care Medicine·2003· 174 cited
Circadian Rhythm of Serum Cortisol after Repeated Inhalation of the New Topical Steroid Ciclesonide
The Journal of Clinical Endocrinology & Metabolism·2002· 89 citedOpen Access
The New Phosphodiesterase 4 Inhibitor Roflumilast Is Efficacious in Exercise‐Induced Asthma and Leads to Suppression of LPS‐Stimulated TNF‐α Ex Vivo
The Journal of Clinical Pharmacology·2002· 123 cited
Pantoprazole lacks interaction with the NSAID naproxen
Gastroenterology·2000· 6 citedOpen Access
TREATMENT OF ARDS WITH rSP-C SURFACTANT.
Shock·1999· 9 cited
The New Topical Steroid Ciclesonide Is Effective in the Treatment of Allergic Rhinitis
The Journal of Clinical Pharmacology·1999· 46 citedOpen Access
Pantoprazole lacks induction of CYP1A2 activity in man.
PubMed·1999· 15 cited
Pantoprazole does not interact with the pharmacokinetics of carbamazepine.
PubMed·1998· 19 cited
The reversible H+,K+-ATPase-antagonist by 841 is more effective in elevating gastric pH in helicobater pylori positive than in Hp-negative volunteers
Gastroenterology·1998· 3 citedOpen Access
Pantoprazole in patients with varying degree of liver impairment in comparison to heal thy controls
Gastroenterology·1998· 4 citedOpen Access
Superiority of 20MG pantoprazole (PANTO) VS 150mg×2 ranitidine (RANI) in healing and symptom relief of patients with mild reflux esophagitis
Gastroenterology·1998· 1 cited
page 1 of 4Next →

Frequent Co-authors

M. Hartmann(21), H Bliesath(21), Reinhard Huber(18), V W Steinijans(13), Reinhold Lühmann(9), Karl Zech(8), Hermann Mascher(5), Wolfgang Timmer(4), Thomas D. Bethke(4), Peter Müller(4), H J Koch(4), F. Rathgeb(4), Anton Drollmann(3), Roger G. Spragg(3), Bernd Simon(3), James F. Lewis(2), Dietrich Häfner(2), Werner Seeger(2), H. W. Radtke(2), H.‐U. Schulz(2)